Bipolar Disorder
📧 Sign up to get email alerts when something new happens for Bipolar Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2020-02-06FDA Approved: ARIPIPRAZOLE — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved Amneal Pharmaceuticals' supplemental abbreviated new drug application for aripiprazole, granting approval of a generic version.
-
FDA approval · 2020-02-05FDA Approved: RISPERDAL CONSTA — Supplemental Application (Janssen Pharmaceuticals, Inc.)
The FDA approved a supplemental application for RISPERDAL CONSTA (risperidone) from Janssen Pharmaceuticals, Inc., signaling an approved mod…
-
FDA approval · 2020-02-05FDA Approved: RISPERDAL M-TAB — Supplemental Application (Janssen Pharmaceuticals, Inc.)
FDA approved a supplemental application for Risperdal M-Tab (risperidone) from Janssen Pharmaceuticals.
-
FDA approval · 2020-02-05FDA Approved: LITHOBID — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved ANI Pharmaceuticals' supplemental application for Lithobid (lithium carbonate).
-
FDA approval · 2020-02-05FDA Approved: RISPERDAL — Supplemental Application (Janssen Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Risperdal (risperidone) from Janssen Pharmaceuticals, Inc. The action updates the product la…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2020-02-05FDA Approved: CHLORPROMAZINE HYDROCHLORIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Chlorpromazine Hydrochloride from Hikma Pharmaceuticals USA Inc.
-
FDA approval · 2020-02-05FDA Approved: ARIPIPRAZOLE — Supplemental Application (Lannett Company, Inc.)
The FDA approves a supplemental application for ARIPIPRAZOLE (Aripiprazole) from Lannett Company, expanding approval of a generic antipsycho…
-
FDA approval · 2020-02-05FDA Approved: ARIPIPRAZOLE — Supplemental Application (Apotex Corp.)
FDA approved Apotex Corp.’s supplemental application for aripiprazole (generic aripiprazole), authorizing the sale of a generic version of t…
-
FDA approval · 2020-02-05FDA Approved: ARIPIPRAZOLE — Supplemental Application (Dr. Reddy's Laboratories Inc)
FDA approved Dr. Reddy's supplemental application to manufacture and market aripiprazole orally disintegrating tablets as a generic product.
-
FDA label_change · 2020-02-05FDA Approved: SEROQUEL — Supplemental Application (H2-Pharma, LLC)
FDA approved a supplemental application for SEROQUEL (quetiapine) submitted by H2-Pharma, LLC, affecting the product labeling. The action re…
-
FDA approval · 2020-02-05FDA Approved: LITHIUM CARBONATE ER — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved a supplemental application for LITHIUM CARBONATE ER from Glenmark Pharmaceuticals Inc., USA, related to the generic lithium car…
-
FDA approval · 2020-02-05FDA Approved: LITHIUM CARBONATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA has approved a supplemental application for lithium carbonate submitted by Hikma Pharmaceuticals USA Inc.
-
FDA approval · 2020-02-05FDA Approved: CHLORPROMAZINE HCI — Supplemental Application (Dr. Reddy's Laboratories Inc.,)
FDA approved a supplemental application for chlorpromazine HCl from Dr. Reddy's Laboratories, confirming the generic product's approval unde…
-
FDA approval · 2020-02-05FDA Approved: ARIPIPRAZOLE — Supplemental Application (Alembic Pharmaceuticals Inc.)
FDA approves a supplemental application for a generic version of aripiprazole from Alembic Pharmaceuticals Inc.
-
FDA approval · 2020-02-04FDA Approved: ARIPIPRAZOLE — Supplemental Application (Alembic Pharmaceuticals Inc.)
FDA approved Alembic Pharmaceuticals' supplemental application to market a generic ARIPIPRAZOLE under an ANDA.
-
FDA approval · 2020-02-04FDA Approved: ARIPIPRAZOLE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for ARIPIPRAZOLE from Aurobindo Pharma Limited, indicating regulatory clearance for changes to the a…
-
FDA approval · 2020-01-30FDA Approved: DIVALPROEX SODIUM — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical Industries' supplemental application for divalproex sodium, resulting in an approved change to the product u…
-
FDA label_change · 2020-01-29FDA Approved: LAMOTRIGINE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
The FDA approved a supplemental application for Lamotrigine filed by Amneal Pharmaceuticals of New York LLC, indicating changes to its label…
-
FDA approval · 2020-01-29FDA Approved: LAMOTRIGINE — Supplemental Application (Dr. Reddys Laboratories Inc.)
The FDA approved a supplemental application for Lamotrigine from Dr. Reddy's Laboratories Inc., authorizing this generic Lamotrigine product…
-
FDA approval · 2020-01-29FDA Approved: LAMOTRIGINE — Supplemental Application (Advagen Pharma Limited)
The FDA approved Advagen Pharma Limited's supplemental application for lamotrigine (generic lamotrigine). This is a supplemental approval fo…
-
CLINICAL_TRIALS trial_result · 2020-01-29Clinical Trial Update: Genetic Predictors of Lithium Response in Bipolar Disorder
A completed clinical trial evaluating genetic predictors of lithium response in bipolar disorder, with results posted in 2020.
-
FDA approval · 2020-01-29FDA Approved: LAMOTRIGINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for lamotrigine from Sun Pharmaceutical Industries, resulting in an approved generic lamotrigine pro…
-
FDA approval · 2020-01-27FDA Approved: QUETIAPINE EXTENDED RELEASE — Supplemental Application (ACI Healthcare USA, Inc.)
FDA approved a supplemental application for Quetiapine Extended Release, enabling the generic product by ACI Healthcare USA, Inc. to be mark…
-
FDA approval · 2020-01-23FDA Approved: GEODON — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for Geodon (ziprasidone) submitted by Viatris Specialty LLC.
-
FDA approval · 2020-01-23FDA Approved: QUETIAPINE EXTENDED-RELEASE — Supplemental Application (AlignScience Pharma Inc.)
FDA approved AlignScience Pharma's supplemental ANDA for a quetiapine extended-release product, making a generic version of quetiapine exten…